Search

everythinglearnresearchcommunity

for

Search:↓

Scientists created MUSIi010-A, a stem cell line from a balding man's scalp, to study hair loss and develop potential treatments.

Tofacitinib is safe and effective for severe alopecia areata, but hair loss may return 2 months after stopping treatment.

Budesonide is not effective for maintaining remission in Crohn's disease beyond three months.

The drug IPI-926 is safe at 160 mg daily and may help treat certain tumors, especially basal cell carcinoma.

Women with PCOS have a higher chance of experiencing depression, anxiety, and sleep disorders.

Chitosan, a natural substance, can be used to create tiny particles that effectively deliver various types of drugs, but more work is needed to improve stability and control of drug release.

PCOS is a common hormonal disorder in women, marked by symptoms like hair growth and menstrual issues, and requires personalized treatment.

Methotrexate is a key, cost-effective drug for skin conditions, but requires careful monitoring for side effects.

Women with PCOS often have skin problems like excessive hair, acne, hair loss, and dark patches, which can be treated with hormonal and non-hormonal therapies.

The document concludes that electrolysis and thermolysis can permanently remove hair but calls for better regulation to ensure safety, and notes a possibility of hair regrowth and rare complications.

Ginseng may help treat cancer and reduce treatment side effects, but more research is needed.

Tofacitinib 2% ointment helped hair regrow in 3 out of 10 patients with alopecia areata, but caused side effects like scalp irritation and raised cholesterol in some.

New understanding of the causes of primary cicatricial alopecia has led to better diagnosis and potential new treatments.

Micropigmentation is a widely accepted tattooing technique for hiding cosmetic issues and medical uses, with permanent results and few side effects, but risks infection if not done with sterile tools.

New treatments for a chronic skin condition show promise, but individualized plans are crucial due to varying responses.

New skin substitutes for treating severe burns and chronic wounds are being developed, but a permanent solution for deep wounds is not yet available commercially.

The document concludes that eyelash trichomegaly, which is the abnormal growth of eyelashes, can be present from birth, caused by diseases, or result from certain medications.

Different sPLA2 enzymes affect immunity, skin and hair health, reproduction, and may be potential targets for therapy.

Interferons are effective for some skin conditions and cancers, but can have side effects and need more research for optimal use.

Stem cell therapy is promising for treating various health conditions, but more research is needed to understand its full potential and address challenges.

The Androgen Receptor could be a target for treating diseases like cancer, but more research is needed to confirm the effectiveness of potential treatments.

Mesotherapy is not significantly better than minoxidil for treating male hair loss.

The medication combination did not affect glucose tolerance but increased some cholesterol levels due to its estrogen component.

Myoblast transplantation shows promise for treating various muscle and heart conditions.

Guasha changed rat skin appearance and blood vessels temporarily without affecting certain nerve proteins or fiber structure.

Biologic therapies can cause various adverse events, but allergy/immunology clinicians can manage them.

Treating hidradenitis suppurativa needs long-term care and teamwork among doctors, but there's a lack of strong guidance on how to do it.

Alopecia Areata is an autoimmune condition causing hair loss, influenced by genetics, environment, and possibly improved by anti-MIF therapy, with many patients experiencing regrowth within a year.

Dilated pupils can be an early sign of HIV/AIDS.

Some cosmetic procedures show promise for treating hair loss, but more research is needed to confirm their safety and effectiveness.